Alan W. Seadler, Ph.D.
Dr. Alan Seadler has had an extensive career spanning both academic and industrial bio-medicine as well as entrepreneurship. Prior experiences include management positions at Ciba-Corning, Fisher Scientific, and Amersham Life Science. In addition, Seadler has held senior management positions with several area startups including BDS and Visible Genetics and was Chief Operating Officer at Cellomics Inc., a drug discovery company now part of ThermoFisher. He was Chief Executive Officer for Crystalplex a start-up nanotechnology company immediately before joining Duquesne University.
Seadler worked in the areas of economic development as vice-president at the Pittsburgh Life Sciences Greenhouse in charge of its incubator and Executive-In-Residence programs. This experience proved useful to helping Duquesne and its partners win designation of a Keystone Innovation Zone for central Pittsburgh.
Seadler sits on the board of directors for the Pittsburgh Tissue Engineering Initiative and the National Institute for Pharmaceutical Technology and Education and has participated in numerous grant review committees.
He holds a Bachelor of Arts from Case Western Reserve University and a Ph.D. in Biology from Case Western Reserve University.